Management of Upper Gastrointestinal Bleeding
The management of upper gastrointestinal bleeding requires immediate resuscitation, risk assessment, early endoscopy within 24 hours, and appropriate endoscopic hemostasis based on bleeding stigmata. 1
Initial Assessment and Resuscitation
Hemodynamic Stabilization
- Immediate fluid resuscitation should be initiated for patients with hemodynamic instability 1
- Use crystalloid fluids (e.g., normal saline, Ringer's lactate) as first-line for volume replacement 1
- Establish adequate IV access for fluid and blood product administration 2
Blood Transfusion Strategy
- For patients without cardiovascular disease: transfuse when hemoglobin is <80 g/L 1
- For patients with cardiovascular disease: use a higher hemoglobin threshold for transfusion 1
- Follow a restrictive transfusion strategy to avoid complications of overtransfusion 1
Risk Assessment
- Use the Glasgow Blatchford Score (GBS) to identify patients at very low risk (score ≤1) who may not require hospitalization or inpatient endoscopy 1
- Do not use the AIMS65 score to identify low-risk patients 1
Pre-Endoscopic Management
Nasogastric Tube Placement
- Consider nasogastric tube placement in selected patients for prognostic value 1, 2
- Use 8-12 French tube for adequate drainage of blood and clots 2
- Apply low intermittent suction (60-80 mmHg) rather than continuous suction 2
Medication Management
- Administer pre-endoscopic proton pump inhibitor (PPI) therapy to downstage endoscopic lesions, but do not delay endoscopy 1
- Do not routinely use promotility agents before endoscopy 1
- For patients on anticoagulants (vitamin K antagonists, DOACs), do not delay endoscopy 1
Endoscopic Management
Timing of Endoscopy
- Perform early endoscopy (within 24 hours of presentation) for all admitted patients with acute UGIB 1, 3
- Consider very early endoscopy (<12 hours) for patients with hemodynamic instability despite resuscitation 4
Endoscopic Hemostasis Based on Stigmata
High-risk stigmata requiring endoscopic therapy:
Low-risk stigmata not requiring endoscopic therapy:
Endoscopic Hemostasis Techniques
- Do not use epinephrine injection alone; always combine with another method 1, 4
- Options for combination therapy include:
Post-Endoscopic Management
Pharmacological Therapy
- For patients who received endoscopic hemostasis, administer high-dose PPI therapy (80 mg IV bolus followed by 8 mg/hour continuous infusion for 72 hours) 4
- Continue PPI therapy after the initial treatment period 4
Monitoring and Follow-up
- Do not routinely perform second-look endoscopy 4
- For patients with clinical evidence of rebleeding after initial successful endoscopic hemostasis, perform repeat endoscopy 4
- If second endoscopic treatment fails, consider transcatheter angiographic embolization or surgery 4, 7
Discharge Planning
- Patients at low risk for rebleeding based on clinical and endoscopic criteria may be discharged promptly after endoscopy 1
- Test for Helicobacter pylori in the acute setting and initiate appropriate antibiotic therapy when detected 4
- For patients on low-dose aspirin for secondary cardiovascular prevention who develop peptic ulcer bleeding:
- Resume aspirin immediately after endoscopy if rebleeding risk is low
- For high-risk ulcers, reintroduce aspirin by day 3 after adequate hemostasis 4
Special Considerations
Coagulopathy Management
- Do not delay endoscopy for mild to moderate coagulopathy 2
- Correct severe coagulopathy on a case-by-case basis 2